BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11598446)

  • 21. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of renal-sparing surgery for renal cell carcinoma.
    Novick AC
    Semin Urol; 1992 Feb; 10(1):12-5. PubMed ID: 1565898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current controversies in nephron-sparing surgery for renal-cell carcinoma.
    Steinbach F; Stöckle M; Hohenfellner R
    World J Urol; 1995; 13(3):163-5. PubMed ID: 7550388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Conservative surgery for renal carcinoma].
    González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
    Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.
    Fergany AF; Hafez KS; Novick AC
    J Urol; 2000 Feb; 163(2):442-5. PubMed ID: 10647650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].
    Arnoux V; Descotes JL; Sengel C; Terrier N; Rambeaud JJ; Long JA
    Prog Urol; 2013 Feb; 23(2):99-104. PubMed ID: 23352302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and oncologic outcomes after nephron-sparing surgery in a solitary kidney: 10 years of experience.
    Costabel JI; Marchinena PG; Tirapegui F; Dantur A; Jurado A; Gueglio G
    Int Braz J Urol; 2016; 42(2):253-61. PubMed ID: 27256179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.
    Pahernik S; Roos F; Hampel C; Gillitzer R; Melchior SW; Thüroff JW
    J Urol; 2006 Jun; 175(6):2027-31. PubMed ID: 16697793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
    Bigot P; Hétet JF; Bernhard JC; Fardoun T; Audenet F; Xylinas E; Ploussard G; Pignot G; Bessede T; Ouzaid I; Robine E; Brureau L; Merigot de Treigny O; Maurin C; Long JA; Rouffilange J; Hoarau N; Lebdai S; Rouprêt M; Bastien L; Neuzillet Y; Mongiat-Artus P; Verhoest G; Zerbib M; Ravery V; Rigaud J; Bellec L; Baumert H; Chautard D; Bensalah K; Escudier B; Paparel P; Grenier N; Rioux-Leclercq N; Azzouzi AR; Soulié M; Patard JJ
    Clin Genitourin Cancer; 2014 Feb; 12(1):e19-27. PubMed ID: 24210610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
    Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
    World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Local recurrence after organ saving kidney tumor surgery].
    Brkovic D; Riedasch G; Waldherr R; Röhl L; Staehler G
    Urologe A; 1994 Mar; 33(2):104-9. PubMed ID: 8178403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.